American Academy of Child and Adolescent Psychiatry 63rd Annual Meeting Program Schedule
Please note that this schedule is subject to change.

Symposium (open)
Emerging Biomarkers for Autism Spectrum Disorder: Using Technology to Revolutionize Clinical Trials and Establish Novel Therapeutics
Saturday, October 29, 2016: 1:30 PM-4:30 PM
Chairs:
Discussant:
 
The Promise of Electroencephalography, Eye Tracking, and Neuroimaging Measures for Use in Autism Spectrum Disorder Clinical Trials
Geraldine Dawson, PhD Duke University School of Medicine, Durham, NC
 
Eye Tracking in Early Autism Spectrum Disorder: Utility as a Marker in Clinical Trials
Frederick Shic, PhD Yale University, New Haven, CT
 
Emerging Technologies for Multimodal Assessment of Autism Spectrum Disorder in Laboratory and Naturalistic Settings: Utility for Biobehavioral Phenotyping
Matthew Goodwin, PhD Northeastern University Bouve College of Health Sciences, Boston, MA
 
Development of a System of Tools and Technologies to Optimize Clinical Trials for Autism Spectrum Disorders
Gahan J. Pandina, PhD Janssen Research & Development, Titusville, NJ

See more of: Symposium
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.